About Accelus
Accelus is a Healthcare company based in Palm Beach Gardens (United States) founded in 2021. Spine surgery robot systems are provided for healthcare industries. It operates in the Healthcare and Industrial Goods & Manufacturing sectors. Accelus has raised $25.64 million across 6 funding rounds from investors including Symbiotic Capital and CHP Merger Corp. The company has 101 employees. Its chief executive, as recorded, is Kevin McGann. Accelus offers products and services including FlareHawk Interbody Fusion System, LineSider Spinal System, Toro-L Interbody Fusion System, and Bionest Demineralized Bone Matrix. Its focus areas include High Tech, Professional Service Robots, Surgery and Spine Surgery. Its legal entity is INTEGRITY IMPLANTS INC. Its competitors include Nevro, PROCEPT BioRobotics and Auris Health; 3 of its 3 listed competitors have raised funding.
Company details
Accelus was established in 2021 in Palm Beach Gardens, United States, within the healthcare sector. Robot systems for spine surgery are developed and supplied, encompassing fusion robots, lumbar fusion devices, interbody fusion devices, navigation robots, and related accessories. Additional components such as targeting tools, semi-automatic positioning systems, cameras, and workflow management tools are included in the offerings to support surgical procedures.
- Headquarters Palm Beach Gardens, United States
- Employees 101
- SectorsHealthcareIndustrial Goods & Manufacturing
- Email••••••••
- Phone•••• ••••
- Website accelusinc.com
- Social LinkedIn
- Legal Name Integrity Implants Inc
- Total Equity Funding$25.64M (USD)
in 6 rounds
- Latest Funding Round$6.08M (USD), Series D
May 2025
- InvestorsSymbiotic Capital
& 1 more
- Employee Count101
Products & Services of Accelus
Accelus offers a comprehensive portfolio of products and services, including FlareHawk Interbody Fusion System, LineSider Spinal System, Toro-L Interbody Fusion System, and Bionest Demineralized Bone Matrix.
Expandable device for transforaminal lumbar interbody fusion surgeries.
Posterior fixation system for spine stabilization procedures.
Lateral interbody device to support fusion in spine surgeries.
Bone matrix product for enhancing spinal fusion outcomes.
Funding Insights of Accelus
Accelus has successfully raised a total of $25.64M across 6 strategic funding rounds. The most recent funding activity was a Series D round of $6.08 million completed in May 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $25.64M
- Total Rounds 6
- Last Round Series D — $6.08M
- First Round $4.07M
(Apr 2016)
- Investors Count 2
All 6 funding rounds of Accelus with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2025 | $6.08M | Series D | – | Concord Health Partners | – |
| Jan 2024 | $20M | Debt – Conventional | – | – | |
| Jul 2022 | $12M | Series D | – | Concord Health Partners | – |
| Jul 2021 | $2.69M | Seed | – | – | – |
| Feb 2020 | $804,882 | Series A | – | – | – |
| Apr 2016 | $4.07M | Series A | – | – | – |
2 investors in total: 2 institutional.
Investors in Accelus
Accelus has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Symbiotic Capital and CHP Merger Corp.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Invests in healthcare IT and services to advance patient care and efficiency. | 2019 | concordhp.com | Summit, United States | |
Healthcare credit solutions are offered by Symbiotic Capital. | symbcap.com | Los Angeles, United States |
Investor details for Accelus
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Accelus
6 people are tracked at Accelus (3 in leadership, 3 in team); the tracked headcount is 101.
| Name | Role | Group |
|---|---|---|
Kevin McGann | CEO | Leadership |
Chris Walsh | Co-founder | Leadership |
Jose Calleja | Executive Vice President, International | Leadership |
Sally Kachenko | Clinical Specialist | Team |
Brittany Griffith | Clinical Development Manager | Team |
Pippi Thompson | Sr. Clinical Development Manager | Team |
Complete people profiles for Accelus
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Accelus
3 dated milestones of Accelus across 9 years, from founding to its latest funding, stage changes and deals.
- Funding First funding round of $4.1M.
- Founded Accelus is founded.
- Funding Latest funding round, Series D, of $6.1M.
Competitors of Accelus
Accelus has 3 listed competitors in our database, 3 of them funded. They include Nevro, PROCEPT BioRobotics and Auris Health.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| nevro.com | 2006 | Menlo Park, United States | $154.1M | 1,215 | Provider of high-frequency spinal cord stimulation implants | |
| procept-biorobotics.com | 2009 | Redwood, United States | $348.84M | 217 | Robotic waterjet system for prostate tissue removal is developed. | |
| aurishealth.com | 2007 | Redwood, United States | $733.62M | 242 | Robotic microsurgical systems for endoscopy are developed. |
Detailed competitors of Accelus
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Accelus
The website of Accelus (accelusinc.com) receives about 1.9K visits a month.
- Monthly visits1.9K
▲ 41.7% vs previous month
Websites whose visitors overlap most with Accelus. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| truedigitalsurgery.com | 100% | 2.8K | #5,794,715 | View details | |
| revbio.com | 99% | 3.1K | #4,587,659 | View details | |
semmes-murphey.com | semmes-murphey.com | 75% | #2,191,041 | – |
Top companies in Orthopedics
3 companies that operate in the same segment as Accelus (Orthopedics) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of high-frequency spinal cord stimulation implants | 2006 | Menlo Park, California, United States | USD 154.1 M | USD 353.08 M | 1,215 | |
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
Antibody-siRNA complexes are developed for cancer treatment. | 2012 | San Diego, California, United States | USD 142.54 M | USD 10.9 M | 391 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Accelus
Complete news archive for Accelus
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Accelus
Accelus was founded in 2021.
Accelus is headquartered in Palm Beach Gardens, United States. It is registered at Palm Beach Gardens, Florida, United States.
Kevin McGann is the CEO of Accelus, as recorded in our data.
Accelus is a funded company, having raised a total of $25.64M across 6 funding rounds to date. The company's 1st funding round was a Series A of $4.07M, raised on Apr 2016.
Accelus has 101 employees.
Accelus was established in 2021 in Palm Beach Gardens, United States, within the healthcare sector. Robot systems for spine surgery are developed and supplied, encompassing fusion robots, lumbar fusion devices, interbody fusion devices, navigation robots, and related accessories. Additional components such as targeting tools, semi-automatic positioning systems, cameras, and workflow management tools are included in the offerings to support surgical procedures.
Accelus's top competitors include PROCEPT BioRobotics, Nevro and Auris Health.
Accelus offers FlareHawk Interbody Fusion System, LineSider Spinal System, Toro-L Interbody Fusion System, and Bionest Demineralized Bone Matrix.
Accelus has 2 investors. Key investors include Symbiotic Capital, and CHP Merger Corp.
Accelus operates through Integrity Implants Inc.